Report Detail
Global Generic Drugs Market Growth 2019-2024
- RnM2975559 |
- 18 February, 2019 |
- Global |
- 167 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
The global average gross margin of generic drugs is in the decreasing trend, from 45.19% in 2011 to 43.56% in 2015. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
The classification of generic drugs includes simple generic drugs, super generic drugs and biosimilars. And the proportion of simple generic drugs in 2015 is about 80% and the proportion is in decreasing trend from 2011 to 2015. The super generic drugs in 2015 are about 18.7% and the proportion is in increasing trend from 2011 to 2015.
North America region is the largest supplier of generic drugs, with a revenue market share nearly 31.5% in 2015. Europe is the second largest supplier of generic drugs, enjoying revenue market share nearly 26.5% in 2015, India is also an important areas, and with the revenue market share is 22.8% in 2015.
According to this study, over the next five years the Generic Drugs market will register a 9.8% CAGR in terms of revenue, the global market size will reach US$ 369400 million by 2024, from US$ 210800 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Generic Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic Drugs market by product type, application, key manufacturers and key regions and countries.
This study considers the Generic Drugs value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Simple Generic Drugs
Super Generic Drugs
Biosimilars
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Teva
Novartis - Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Generic Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Generic Drugs market by identifying its various subsegments.
Focuses on the key global Generic Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Generic Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Generic Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Generic Drugs Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Generic Drugs Consumption 2014-2024
- 2.1.2 Generic Drugs Consumption CAGR by Region
- 2.2 Generic Drugs Segment by Type
- 2.2.1 Simple Generic Drugs
- 2.2.2 Super Generic Drugs
- 2.2.3 Biosimilars
- 2.3 Generic Drugs Consumption by Type
- 2.3.1 Global Generic Drugs Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Generic Drugs Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Generic Drugs Sale Price by Type (2014-2019)
- 2.4 Generic Drugs Segment by Application
- 2.4.1 CNS
- 2.4.2 Cardiovascular
- 2.4.3 Genitourinary/Hormonal Drugs
- 2.4.4 Respiratory
- 2.4.5 Rheumatology
- 2.4.6 Diabetes
- 2.4.7 Oncology
- 2.4.8 Others
- 2.5 Generic Drugs Consumption by Application
- 2.5.1 Global Generic Drugs Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Generic Drugs Value and Market Share by Application (2014-2019)
- 2.5.3 Global Generic Drugs Sale Price by Application (2014-2019)
3 Global Generic Drugs by Players
- 3.1 Global Generic Drugs Sales Market Share by Players
- 3.1.1 Global Generic Drugs Sales by Players (2017-2019)
- 3.1.2 Global Generic Drugs Sales Market Share by Players (2017-2019)
- 3.2 Global Generic Drugs Revenue Market Share by Players
- 3.2.1 Global Generic Drugs Revenue by Players (2017-2019)
- 3.2.2 Global Generic Drugs Revenue Market Share by Players (2017-2019)
- 3.3 Global Generic Drugs Sale Price by Players
- 3.4 Global Generic Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Generic Drugs Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Generic Drugs Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Generic Drugs by Regions
- 4.1 Generic Drugs by Regions
- 4.1.1 Global Generic Drugs Consumption by Regions
- 4.1.2 Global Generic Drugs Value by Regions
- 4.2 Americas Generic Drugs Consumption Growth
- 4.3 APAC Generic Drugs Consumption Growth
- 4.4 Europe Generic Drugs Consumption Growth
- 4.5 Middle East & Africa Generic Drugs Consumption Growth
5 Americas
- 5.1 Americas Generic Drugs Consumption by Countries
- 5.1.1 Americas Generic Drugs Consumption by Countries (2014-2019)
- 5.1.2 Americas Generic Drugs Value by Countries (2014-2019)
- 5.2 Americas Generic Drugs Consumption by Type
- 5.3 Americas Generic Drugs Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Generic Drugs Consumption by Countries
- 6.1.1 APAC Generic Drugs Consumption by Countries (2014-2019)
- 6.1.2 APAC Generic Drugs Value by Countries (2014-2019)
- 6.2 APAC Generic Drugs Consumption by Type
- 6.3 APAC Generic Drugs Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Generic Drugs by Countries
- 7.1.1 Europe Generic Drugs Consumption by Countries (2014-2019)
- 7.1.2 Europe Generic Drugs Value by Countries (2014-2019)
- 7.2 Europe Generic Drugs Consumption by Type
- 7.3 Europe Generic Drugs Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Generic Drugs by Countries
- 8.1.1 Middle East & Africa Generic Drugs Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Generic Drugs Value by Countries (2014-2019)
- 8.2 Middle East & Africa Generic Drugs Consumption by Type
- 8.3 Middle East & Africa Generic Drugs Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Generic Drugs Distributors
- 10.3 Generic Drugs Customer
11 Global Generic Drugs Market Forecast
- 11.1 Global Generic Drugs Consumption Forecast (2019-2024)
- 11.2 Global Generic Drugs Forecast by Regions
- 11.2.1 Global Generic Drugs Forecast by Regions (2019-2024)
- 11.2.2 Global Generic Drugs Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Generic Drugs Forecast by Type
- 11.8 Global Generic Drugs Forecast by Application
12 Key Players Analysis
- 12.1 Teva
- 12.1.1 Company Details
- 12.1.2 Generic Drugs Product Offered
- 12.1.3 Teva Generic Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Teva News
- 12.2 Novartis - Sandoz
- 12.2.1 Company Details
- 12.2.2 Generic Drugs Product Offered
- 12.2.3 Novartis - Sandoz Generic Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Novartis - Sandoz News
- 12.3 Mylan
- 12.3.1 Company Details
- 12.3.2 Generic Drugs Product Offered
- 12.3.3 Mylan Generic Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Mylan News
- 12.4 Sun Pharmaceutical
- 12.4.1 Company Details
- 12.4.2 Generic Drugs Product Offered
- 12.4.3 Sun Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Sun Pharmaceutical News
- 12.5 Aspen
- 12.5.1 Company Details
- 12.5.2 Generic Drugs Product Offered
- 12.5.3 Aspen Generic Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Aspen News
- 12.6 Fresenius Kabi
- 12.6.1 Company Details
- 12.6.2 Generic Drugs Product Offered
- 12.6.3 Fresenius Kabi Generic Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Fresenius Kabi News
- 12.7 Pfizer (Hospira)
- 12.7.1 Company Details
- 12.7.2 Generic Drugs Product Offered
- 12.7.3 Pfizer (Hospira) Generic Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Pfizer (Hospira) News
- 12.8 Sanofi
- 12.8.1 Company Details
- 12.8.2 Generic Drugs Product Offered
- 12.8.3 Sanofi Generic Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Sanofi News
- 12.9 Aurobindo
- 12.9.1 Company Details
- 12.9.2 Generic Drugs Product Offered
- 12.9.3 Aurobindo Generic Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Aurobindo News
- 12.10 Lupin
- 12.10.1 Company Details
- 12.10.2 Generic Drugs Product Offered
- 12.10.3 Lupin Generic Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Lupin News
- 12.11 Dr. Reddy's
- 12.12 Apotex
- 12.13 Cipla
- 12.14 ENDO (Par Pharmaceutical)
- 12.15 Stada Arzneimittel
- 12.16 Krka Group
- 12.17 Nichi-Iko Pharmaceutical
- 12.18 Valeant
- 12.19 Zydus Cadila
- 12.20 Hikma
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Generic Drugs . Industry analysis & Market Report on Generic Drugs is a syndicated market report, published as Global Generic Drugs Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Generic Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
